Blase Polite to Neoplasms
This is a "connection" page, showing publications Blase Polite has written about Neoplasms.
Connection Strength
4.954
-
Improving End of Life Cancer Outcomes Through Development and Implementation of a Spiritual Care Advocate Program. Am J Hosp Palliat Care. 2021 Dec; 38(12):1441-1450.
Score: 0.231
-
Oncology's "Hockey Stick" Moment for the Cost of Cancer Drugs-The Climate Is About to Change. JAMA Oncol. 2021 01 01; 7(1):25-26.
Score: 0.228
-
"Let Go, Let God": A Qualitative Study Exploring Cancer Patients' Spirituality and Its Place in the Medical Setting. J Relig Health. 2020 Oct; 59(5):2341-2363.
Score: 0.225
-
Bending Versus Transforming the Drug Cost Curve: A Matter of Political Will. Cancer J. 2020 Jul/Aug; 26(4):304-310.
Score: 0.221
-
Formal Assessment of Teamwork Among Cancer Health Care Professionals in Three Large Tertiary Centers in Nigeria. JCO Glob Oncol. 2020 04; 6:560-568.
Score: 0.217
-
Ensuring Equity and Justice in the Care and Outcomes of Patients With Cancer. JAMA. 2019 May 07; 321(17):1663-1664.
Score: 0.204
-
State of Cancer Care in America: Reflections on an Inaugural Year. J Oncol Pract. 2019 04; 15(4):163-165.
Score: 0.202
-
Investigation of a multimedia, computer-based approach to improve knowledge, attitudes, self-efficacy, and receptivity to cancer clinical trials among newly diagnosed patients with diverse health literacy skills. Cancer. 2019 06 15; 125(12):2066-2075.
Score: 0.201
-
A New Look at the State of Cancer Care in America. J Oncol Pract. 2018 07; 14(7):397-399.
Score: 0.191
-
A Rules-Based Algorithm to Prioritize Poor Prognosis Cancer Patients in Need of Advance Care Planning. J Palliat Med. 2018 06; 21(6):846-849.
Score: 0.188
-
The Road From Theory to Reality: Illuminating the Complexity of Prospective Cancer Bundles. J Oncol Pract. 2018 02; 14(2):59-61.
Score: 0.186
-
Blase Polite on How Disparities Research Must Move Into an Era of Action. Oncology (Williston Park). 2017 10 15; 31(10):709-10, 717.
Score: 0.183
-
Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. J Clin Oncol. 2017 09 10; 35(26):3075-3082.
Score: 0.180
-
Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. CA Cancer J Clin. 2017 09; 67(5):353-361.
Score: 0.180
-
Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. Cancer Res. 2017 09 01; 77(17):4548-4555.
Score: 0.180
-
Pursuing Value in Cancer Care: A Model in Progress. J Oncol Pract. 2017 07; 13(7):407-409.
Score: 0.179
-
Implementation of Advance Care Planning in Oncology: A Review of the Literature. J Oncol Pract. 2017 10; 13(10):657-662.
Score: 0.178
-
No Exit: Identifying Avoidable Terminal Oncology Intensive Care Unit Hospitalizations. J Oncol Pract. 2016 10; 12(10):e901-e911.
Score: 0.170
-
An Evaluation of Psychosocial and Religious Belief Differences in a Diverse Racial and Socioeconomic Urban Cancer Population. J Racial Ethn Health Disparities. 2017 04; 4(2):140-148.
Score: 0.164
-
Reply to M. Thompson et Al. J Oncol Pract. 2015 May; 11(3):263-4.
Score: 0.152
-
Medicare innovation center oncology care model: a toe in the water when a plunge is needed. J Oncol Pract. 2015 Mar; 11(2):117-9.
Score: 0.152
-
Reform of the Buy-and-Bill System for Outpatient Chemotherapy Care Is Inevitable: Perspectives from an Economist, a Realpolitik, and an Oncologist. Am Soc Clin Oncol Educ Book. 2015; e75-80.
Score: 0.151
-
Payment for oncolytics in the United States: a history of buy and bill and proposals for reform. J Oncol Pract. 2014 Nov; 10(6):357-62.
Score: 0.149
-
Achieving a deeper understanding of the implemented provisions of the Affordable Care Act. Am Soc Clin Oncol Educ Book. 2014; e472-7.
Score: 0.141
-
Oncology Medical Homes: ASCO-Community Oncology Alliance Standards. JCO Oncol Pract. 2026 Mar; 22(3):365-374.
Score: 0.078
-
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors. Clin Cancer Res. 2021 10 15; 27(20):5510-5518.
Score: 0.059
-
Opaque Results of Federal Price Transparency Rules and State-Based Alternatives. J Oncol Pract. 2019 09; 15(9):463-464.
Score: 0.052
-
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2018 08; 82(2):309-317.
Score: 0.048
-
Analyzing the clinical actionability of germline pharmacogenomic findings in oncology. Cancer. 2018 07 15; 124(14):3052-3065.
Score: 0.048
-
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received. J Clin Oncol. 2016 08 20; 34(24):2925-34.
Score: 0.042
-
Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide. Clin Cancer Res. 2015 Nov 15; 21(22):5092-9.
Score: 0.039
-
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. J Clin Oncol. 2015 Aug 10; 33(23):2563-77.
Score: 0.039
-
Phase I dose-escalation study of onartuzumab as a single agent and in combination with bevacizumab in patients with advanced solid malignancies. Clin Cancer Res. 2014 Mar 15; 20(6):1666-75.
Score: 0.035
-
Infused chemotherapy use in the elderly after patent expiration. Am J Manag Care. 2012 May 01; 18(5):e173-8.
Score: 0.031
-
American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities. J Clin Oncol. 2011 Oct 01; 29(28):3816-24.
Score: 0.030